Tower Research Capital LLC (TRC)

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 1533421 NEW YORK, NY

Position in CRBP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,422

-$26,925 QoQ

Shares Held

684

-85.8% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $67,026,208 across 431 Biotechnology names. CRBP ranks #300 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	12,112	$8,844,787
2	VRTX	Vertex Pharmaceuticals Inc / Ma	13,904	$6,208,692
3	REGN	Regeneron Pharmaceuticals, Inc.	4,378	$3,382,617
4	ALNY	Alnylam Pharmaceuticals, Inc.	9,627	$3,185,285
5	INSM	INSMED Inc	15,410	$2,519,843
6	LKFT	Lakefront Biotherapeutics NV	66,536	$1,996,080
7	MRNA	Moderna, Inc.	33,728	$1,713,382
8	BBIO	BridgeBio Pharma, Inc.	14,349	$1,065,556

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,422	684	-85.8%	Shares	Defined	2026-05-15
2025-06-30	$33,347	4,833	+70.7%	Shares	Other	2025-08-15
2025-03-31	$15,032	2,831	-40.1%	Shares	Defined	2025-05-15
2024-12-31	$55,766	4,726	-63.2%	Shares	Other	2025-02-13
2024-09-30	$265,135	12,852	+1773.5%	Shares	Other	2024-11-14
2024-06-30	$31,041	686	-60.3%	Shares	Defined	2024-08-13
2024-03-31	$67,728	1,726	+45.0%	Shares	Defined	2024-05-15
2023-12-31	$7,187	1,190	+709.5%	Shares	Defined	2024-02-13
2023-06-30	$1,152	147	-72.5%	Shares	Defined	2023-08-14
2023-03-31	$3,888	535	—	Shares	Defined	2023-05-09
No filing history on record for this holder in this stock.